About: Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 March 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) artículu científicu espublizáu en marzu de 2019 (ast) наукова стаття, опублікована у квітні 2019 (uk) scientific article published on 07 March 2019 (en)
publication date	wds:Q64119716-1099DEA2-A737-49CE-AD85-D581B8F23412
publication date	2019-03-07 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64119716-1B0698F0-56BF-46BB-A984-49A0A1DEF5B7
language of work or name	English
cites work	wds:Q64119716-0314F8C6-1400-414F-A7C6-3DCA739FBD5F wds:Q64119716-3BB11D61-DA8E-4CE4-B317-6518A7218A36 wds:Q64119716-3C3F48EF-4F49-429A-AB0B-51298E9A34FB wds:Q64119716-5FF9AC73-FBBE-4C85-845D-D9E4059E27A9 wds:Q64119716-6338783A-96D7-42D4-AEA9-0977858A7C3A wds:Q64119716-707F8E71-C9D8-4E28-AF7D-57F3FCA4BB4A wds:Q64119716-7A3C6490-5C61-4860-8FA4-0740360DD5FA wds:Q64119716-83C4CC88-4DCD-445C-A4F4-888296FC091C wds:Q64119716-85BACC6C-F6A1-430E-846F-C3DAE3E2236C wds:Q64119716-9CB297BA-3D5E-46E3-9EF0-BC2F2ECB4BF8 wds:Q64119716-9DE164B7-4674-447D-930A-0B1C883FD5C1 wds:Q64119716-A528D2AD-3587-4F08-A6C2-B651DA762B61 wds:Q64119716-A8E42C85-5BC5-4975-91CE-8F0F1570CB26 wds:Q64119716-BC492B94-FB99-4351-9B2D-121B44E38D31 wds:Q64119716-CAC8CCA2-0A5D-446C-BD12-2AE0E75666B4 wds:Q64119716-D5FDC200-CB14-4438-A9A1-A0C8EC3BC8C5 wds:Q64119716-DF043AE4-A99D-4173-83F3-0BA64ABDF4EA wds:Q64119716-F879AAD5-17A3-4C88-93E2-749AF7BED46D
cites work	Global cancer statistics, 2012 Global cancer statistics Evaluation of the quality of prognosis studies in systematic reviews Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis Long-term survival is linked to serum LDH and partly to tumour LDH-5 in NSCLC. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study. Monitoring immune-checkpoint blockade: response evaluation and biomarker development Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer. Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib. Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab. Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients.
author name string	wds:Q64119716-5097C92B-4CE0-455A-AE5F-7CF31F968CBA wds:Q64119716-650A2E8B-7C71-4BD2-90E6-B1161E7C0B20 wds:Q64119716-8B3BE33C-6E8D-4C51-8158-DE96A247CEA8 wds:Q64119716-EA3E67C6-F484-466F-A542-46DB92281E4D
author name string	Xiang Yan Jinliang Wang Qi Song Shunchang Jiao
rdfs:label	Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis (en) Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis (nl)
skos:prefLabel	Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis (en) Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis (nl)
name	Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis (en) Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis (nl)
author	wds:Q64119716-17A2FA8C-7D73-40EC-AB18-F9AEAB518396 wds:Q64119716-1EB02CA9-A902-42D8-A66D-8E88A74D0CD5 wds:Q64119716-740FEF33-AAA2-4D15-97BA-EBC8B1038BC1 wds:Q64119716-9BCB6F86-182C-4645-830E-1ABB206B85DE
author	Ye Li Zhibo Zhang Guoqiang Wang Yi Hu
title	wds:Q64119716-6AD98502-A3BF-4478-AF12-2DACC82FC92F
title	Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis (en)
page(s)	wds:Q64119716-7ABB38B7-C8BB-4461-8C0A-062B45C2AB59
page(s)	1467-1473
instance of	wds:Q64119716-250EF336-46E6-4902-8B1B-619454CCCAEC wds:Q64119716-6ed4fb02-0328-482d-aeec-a6b450726624
instance of	meta-analysis scholarly article
main subject	wds:Q64119716-C3F1CE81-B251-4CDC-AB86-30C92E5E42FE wds:Q64119716-EB3CB394-C559-49C4-8567-33BF69755032
main subject	meta-analysis immunotherapy
PubMed ID	wds:Q64119716-9172626E-E670-47AD-AFF6-3F182694A877
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30848091
PubMed ID	30848091
published in	wds:Q64119716-F55FA523-94E7-4D63-9680-41BF4F9EA1CA
published in	Cancer Medicine
issue	wds:Q64119716-0DEED87F-217C-4210-8E17-096470FC7C5F
volume	wds:Q64119716-F59AE741-065F-4839-898E-822BEF81909E
issue	4
volume	8
number of pages	wds:Q64119716-CE6D5251-0BDF-4C0E-9D93-B62EB61B8338
number of pages	7 (xsd:decimal)
DOI	wds:Q64119716-088DA7BA-7106-4EE7-9A0A-A2D7EFD9D8D5
DOI	http://dx.doi.org/10.1002/CAM4.2024
DOI	10.1002/CAM4.2024
PMCID	wds:Q64119716-3C6F0935-CBE4-4A8B-B9CF-9922DE943113
PMCID	6488146
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64119716
is cites work of	Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs) Radiation therapy for augmenting the efficacy of immunotherapy in advanced non-small cell lung cancer: a case-controlled study The usefulness of lactate dehydrogenase measurements in current oncological practice

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software